Atomic Convolutional Networks for Predicting Protein-Ligand Binding Affinity

Abstract

Empirical scoring functions based on either molecular force fields or cheminformatics descriptors are widely used, in conjunction with molecular docking, during the early stages of drug discovery to predict potency and binding affinity of a drug-like molecule to a given target. These models require expert-level knowledge of physical chemistry and biology to be encoded as hand-tuned parameters or features rather than allowing the underlying model to select features in a data-driven procedure. Here, we develop a general 3-dimensional spatial convolution operation for learning atomic-level chemical interactions directly from atomic coordinates and demonstrate its application to structure-based bioactivity prediction. The atomic convolutional neural network is trained to predict the experimentally determined binding affinity of a protein-ligand complex by direct calculation of the energy associated with the complex, protein, and ligand given the crystal structure of the binding pose. Non-covalent interactions present in the complex that are absent in the protein-ligand sub-structures are identified and the model learns the interaction strength associated with these features. We test our model by predicting the binding free energy of a subset of protein-ligand complexes found in the PDBBind dataset and compare with state-of-the-art cheminformatics and machine learning-based approaches. We find that all methods achieve experimental accuracy and that atomic convolutional networks either outperform or perform competitively with the cheminformatics based methods. Unlike all previous protein-ligand prediction systems, atomic convolutional networks are end-to-end and fully-differentiable. They represent a new data-driven, physics-based deep learning model paradigm that offers a strong foundation for future improvements in structure-based bioactivity prediction.

References in corpus (2)

• Google's Neural Machine Translation System: Bridging the Gap between Human and Machine Translation
• Low Data Drug Discovery with One-shot Learning

Cited by in corpus (19)

• WideDTA: prediction of drug-target binding affinity
• Adaptive Graph Convolutional Neural Networks
• Learning Graph-Level Representation for Drug Discovery
• Molecular Mechanics-Driven Graph Neural Network with Multiplex Graph for Molecular Structures
• A critical look at the current train/test split in machine learning
• Multi-View Self-Attention for Interpretable Drug-Target Interaction Prediction
• Ligand Pose Optimization with Atomic Grid-Based Convolutional Neural Networks
• Uncertainty quantification of molecular property prediction with Bayesian neural networks
• DeepAtom: A Framework for Protein-Ligand Binding Affinity Prediction
• Learning a Continuous Representation of 3D Molecular Structures with Deep Generative Models
• Learning Graph While Training: An Evolving Graph Convolutional Neural Network
• Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts
• Predicting drug-target interaction using 3D structure-embedded graph representations from graph neural networks
• Unsupervised learning of dynamical and molecular similarity using variance minimization
• Attribution Methods Reveal Flaws in Fingerprint-Based Virtual Screening
• Uncertainty quantification of molecular property prediction using Bayesian neural network models
• Drug cell line interaction prediction
• Cross-Modality Protein Embedding for Compound-Protein Affinity and Contact Prediction
• libmolgrid: GPU Accelerated Molecular Gridding for Deep Learning Applications